{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lyndhurst",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "82158",
      "recalling_firm": "Amerigen Pharmaceuticals Inc.",
      "address_1": "9 Polito Ave Ste 900",
      "address_2": "",
      "postal_code": "07071-3410",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed to 4 wholesalers/distributors and 1 retail account who may have further distribute the product throughout the United States.",
      "recall_number": "D-0516-2019",
      "product_description": "Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle (NDC 43975-252-14), Rx only, Mfd. by: Stason Pharmaceuticals, Inc., Irvine, CA 92618, Dist. By: Amerigen Pharmaceuticals, Lyndhurst, NJ 07071",
      "product_quantity": "a) 2,413 bottles b) 3,355 bottles",
      "reason_for_recall": "Failed dissolution specifications",
      "recall_initiation_date": "20190219",
      "center_classification_date": "20190220",
      "termination_date": "20191217",
      "report_date": "20190227",
      "code_info": "Lot #: a) 18J043A, Exp 09/30/2020, b) 18J043B, Exp 09/30/2020",
      "more_code_info": ""
    }
  ]
}